• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Down syndrome research biobank launched

Bioengineer by Bioengineer
February 22, 2021
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Cincinnati Children’s Hospital teams with DownSyndrome Achieves

IMAGE

Credit: Cincinnati Children’s

FEB. 22, 2021 – Cincinnati Children’s Hospital Medical Center has collaborated with DownSyndrome Achieves (DSA) to launch a research biobank, which serves as a central repository for biospecimens donated by individuals with Down syndrome and their immediate families.

The DSA Biobank aims to improve clinical care and health outcomes for individuals with Down syndrome and others by housing high-quality, well-annotated biospecimens that aid in driving basic, translational, and clinical research.

The DSA Biobank team at Cincinnati Children’s includes:

  • The laboratory of William Nichols, PhD, associate director of research in the Division of Human Genetics at Cincinnati Children’s
  • The Cincinnati Children’s Discover Together Biobank, which is directed by Michael Pauciulo, MBA.

The Discover Together Biobank at Cincinnati Children’s is a secure facility for a variety of blood, saliva, and tissue samples as well as related information that helps researchers drive scientific breakthroughs.

The DSA Biobank will create an important, novel biospecimen resource for the Down syndrome research community, Dr. Nichols said.

“In leveraging our existing expertise in the collection, processing, and storing of biological specimens and clinical data over the course of the last decade in my laboratory, this new partnership with DownSyndrome Achieves and the Cincinnati Children’s Discover Together Biobank is the continued application and expansion of our biobanking efforts,” Dr. Nichols said.

Incorporated into the DSA Biobank model are many of the Discover Together Biobank’s institutional concepts behind broad consent, sample governance, and wide sharing of biospecimens/data, Pauciulo said.

“This partnership with DSA and Dr. Nichols continues Discover Together down the path of utilizing our biobanking expertise and infrastructure to partner with national and regional research networks,” Pauciulo said. “We couldn’t be more excited to leverage our resources to help DSA improve health outcomes for the Down syndrome population.”

Institutional Review Board protocol has been approved, and a pilot phase of operations has been completed with enrollment from Lee Specialty Clinic in Louisville. Additional Down syndrome clinics are slated to start enrollment later this year, including at Cincinnati Children’s.

Lito Ramirez, CEO of DownSyndrome Achieves, described the new DSA Biobank as a national resource.

“DSA Biobank, in partnership with Cincinnati Children’s Hospital, provides researchers with the potential to unlock some of the mysteries associated with Down syndrome,” Ramirez said. “Currently, researchers do not have readily available blood and other samples to advance our understanding of the conditions that co-occur with Down syndrome. I’m excited the Down syndrome community will have this national resource, which is long overdue.”

###

ABOUT CINCINNATI CHILDREN’S

Cincinnati Children’s Hospital Medical Center has ranked No. 3 or higher in U.S. News & World Report’s annual survey of Best Children’s Hospitals for 10 consecutive years. The hospital’s 1.38 million patient encounters in 2020 included children from 50 states and 51 countries, many of whose families sought care for complex or rare disorders. The medical center also is among top recipients of pediatric research grants bestowed annually by the National Institutes of Health. Nearly one-third of the employees at Cincinnati Children’s are engaged in scientific research.

ABOUT DOWNSYNDROME ACHIEVES

DownSyndrome Achieves is a research advocacy group that envisions a future when Down syndrome comes without health complications. When people with Down syndrome can maximize their potential and lead healthier, more active, and independent lives. That is why we developed the DSA Biobank. Located at Cincinnati Children’s Hospital Medical Center, the DSA Biobank is the first of its kind to catalog, store, and openly share biosamples and associated health data for study. Our keen focus on fostering collaboration allows us to provide researchers with the critical biosamples needed to develop breakthrough treatments and therapies.

Media Contact
Barrett J. Brunsman
[email protected]

Tags: Business/EconomicsCollaborationGenesGeneticsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Predicting Lung Infections After Brain Hemorrhage

Predicting Lung Infections After Brain Hemorrhage

August 2, 2025
blank

Impact of Morphology and Location on Aneurysms

August 2, 2025

Unraveling EMT’s Role in Colorectal Cancer Spread

August 2, 2025

Gut γδ T17 Cells Drive Brain Inflammation via STING

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    40 shares
    Share 16 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Predicting Lung Infections After Brain Hemorrhage

Impact of Morphology and Location on Aneurysms

Unraveling EMT’s Role in Colorectal Cancer Spread

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.